Clinical Scorecard: Helicobacter pylori Infection and Its Impact on Gastric Cancer Patients in French Guiana: A Retrospective Hospital Study (2018–2023)

At a Glance

Key Highlights

• 52.4% of patients were H. pylori-positive.
• H. pylori positivity was associated with non-active chronic gastritis.
• No significant difference in overall survival between H. pylori-positive and negative patients.
• Initial management strategy was strongly associated with patient outcomes.
• Study conducted in a population with high gastric cancer incidence.

Guideline-Based Recommendations

Diagnosis

• Histologically confirm invasive gastric carcinoma.
• Assess H. pylori status through routine histopathology.

Management

• Categorize initial management into surgery, chemotherapy, or palliative care.

Monitoring & Follow-up

• Follow-up until December 31, 2025, for survival analysis.

Risks

• Inconsistent findings regarding the prognostic value of H. pylori infection.

Patient & Prescribing Data

Patients with histologically confirmed invasive gastric carcinoma.

Initial management reflects disease stage rather than treatment effect.

Clinical Best Practices

• Utilize routine histopathology for H. pylori detection.
• Consider the impact of disease stage on treatment outcomes.

Related Resources & Content

• Study on Helicobacter pylori and Gastric Cancer